BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31719051)

  • 21. Evaluating Reporting Completeness of Patient-Reported Outcomes in Esophageal Motility Disorders: A Cross-Sectional Analysis of Randomized Controlled Trials.
    Staggs J; Williams C; Love M; Renner A; Kee M; Hillman C; Shepard S; Heigle B; Rauh S; Ottwell R; Hartwell M; Vassar M
    Dysphagia; 2022 Dec; 37(6):1576-1585. PubMed ID: 35194671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.
    Weingärtner V; Dargatz N; Weber C; Mueller D; Stock S; Voltz R; Gaertner J
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):821-9. PubMed ID: 26959869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice.
    Mercieca-Bebber R; Friedlander M; Calvert M; Stockler M; Kyte D; Kok PS; King MT
    J Patient Rep Outcomes; 2017; 1(1):5. PubMed ID: 29757300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021.
    Efficace F; Cottone F; Sparano F; Caocci G; Vignetti M; Chakraborty R
    Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):442-459. PubMed ID: 35183476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.
    Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M
    J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review.
    Roets E; van der Graaf W; van Riet BHG; Haas RL; Younger E; Sparano F; Wilson R; van der Mierden S; Steeghs N; Efficace F; Husson O
    Crit Rev Oncol Hematol; 2024 May; 197():104345. PubMed ID: 38582227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols.
    Mercieca-Bebber R; Friedlander M; Kok PS; Calvert M; Kyte D; Stockler M; King MT
    Qual Life Res; 2016 Oct; 25(10):2457-2465. PubMed ID: 27294435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Interventions of Post-Traumatic Stress Disorder.
    Hughes G; Sutterfield B; Anderson R; Streck S; Hillman C; Shepard S; Wise A; Ottwell R; Hartwell M; Vassar M
    Psychiatr Q; 2023 Jun; 94(2):127-139. PubMed ID: 36976434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of reporting of patient-reported outcomes in MDD: A meta-epidemiological study of clinical trials.
    Minley K; Smith CA; Batioja K; Andriana Peña BS; Shepard S; Heigle B; Kee M; Wise A; Hillman C; Ottwell R; Hartwell M; Vassar M
    J Psychiatr Res; 2022 Jun; 150():79-86. PubMed ID: 35358835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review.
    Charton E; Cuer B; Cottone F; Efficace F; Touraine C; Hamidou Z; Fiteni F; Bonnetain F; Woronoff-Lemsi MC; Bascoul-Mollevi C; Anota A
    Qual Life Res; 2020 Apr; 29(4):867-878. PubMed ID: 31776827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting.
    Gilbert A; Ziegler L; Martland M; Davidson S; Efficace F; Sebag-Montefiore D; Velikova G
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):555-67. PubMed ID: 26068490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Patient-Reported Outcomes in Inguinal Hernia Clinical Trials.
    Wilcox AR; Trooboff SW; Wong SL
    J Surg Res; 2019 Dec; 244():430-435. PubMed ID: 31326709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review.
    Feuerstein MA; Jacobs M; Piciocchi A; Bochner B; Pusic A; Fayers P; Blazeby J; Efficace F;
    Urol Oncol; 2015 Jul; 33(7):331.e17-23. PubMed ID: 25956189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit.
    Dos Santos M; Brachet PE; Chevreau C; Joly F
    Cancer Treat Rev; 2017 Feb; 53():53-60. PubMed ID: 28073101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?
    Sparano F; Aaronson NK; Cottone F; Piciocchi A; La Sala E; Anota A; Deliu N; Kieffer JM; Efficace F
    J Comp Eff Res; 2019 Apr; 8(5):279-288. PubMed ID: 30838883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating reporting of patient-reported outcomes in peptic ulcer disease: a meta-epidemiological study of randomized controlled trials.
    Anderson RM; Streck S; Hughes G; Sutterfield B; Kee M; Wise A; Hillman C; Ottwell R; Hartwell M; Vassar M
    Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1253-1260. PubMed ID: 36073013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in randomised controlled trials in prevention and management of carious lesions: a systematic review.
    Levey C; Innes N; Schwendicke F; Lamont T; Göstemeyer G
    Trials; 2017 Nov; 18(1):515. PubMed ID: 29096680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: A systematic review.
    Newman C; Kgosidialwa O; Dervan L; Bogdanet D; Egan AM; Biesty L; Devane D; O'Shea PM; Dunne FP
    Diabetes Res Clin Pract; 2022 Jun; 188():109879. PubMed ID: 35483543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive review of statistical methods for analysing patient-reported outcomes (PROs) used as primary outcomes in randomised controlled trials (RCTs) published by the UK's
    Qian Y; Walters SJ; Jacques R; Flight L
    BMJ Open; 2021 Sep; 11(9):e051673. PubMed ID: 34489292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.